ID

24041

Description

Module 1 - Enrolment - Previous study information and eligibility 101468/243 Study ID: 101468/243 Clinical Study ID: 101468/243 Study Title: A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome

Mots-clés

  1. 23/07/2017 23/07/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

23 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK study: Ropinirole in RLS patients 101468/243 - Enrolment, Previous study information and eligibility

GSK study: Ropinirole in RLS patients 101468/243 - Enrolment, Previous study information and eligibility

Previous study information
Description

Previous study information

Alias
UMLS CUI-1
C2603343
UMLS CUI-2
C1533716
UMLS CUI-3
C0205156
Visite date
Description

visit date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Previous SB Protocol Number
Description

Previous Protocol Number

Type de données

text

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0600091
UMLS CUI [1,3]
C0205156
Previous Centre Number
Description

previous centre number

Type de données

text

Alias
UMLS CUI [1,1]
C0019994
UMLS CUI [1,2]
C0600091
UMLS CUI [1,3]
C0205156
Previous Patient Number
Description

The patient number used in the previous study should match the patient number on the header of this page.

Type de données

text

Alias
UMLS CUI [1,1]
C1830427
UMLS CUI [1,2]
C0205156
Please complete the following inclusion criteria
Description

Please complete the following inclusion criteria

Alias
UMLS CUI-1
C1512693
Subjects who have successfully completed Studies 101468/191,194 (US subjects only), or 207
Description

Subject completed previous study

Type de données

integer

Alias
UMLS CUI [1,1]
C2348577
UMLS CUI [1,2]
C0205156
The subject must have given written informed consent prior to any specific study procedures
Description

written informed consent

Type de données

integer

Alias
UMLS CUI [1]
C0021430
Please complete the following exclusion criteria.
Description

Please complete the following exclusion criteria.

Alias
UMLS CUI-1
C0680251
Women of childbearing potential who are not practicing a clinically accepted method of contraception such as oral contraception, surgical sterilization, I.U.D., diaphragm in conjunction with spermicidal foam and condom on the male partner, or systemic contraception (i.e., Norplant*).
Description

childbearing potential and no contraception

Type de données

integer

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
Women who have a positive pregnancy test.
Description

pregnancy test positive

Type de données

integer

Alias
UMLS CUI [1]
C0240802
Subjects who have developed any medically unstable illnesses
Description

unstable health condition

Type de données

integer

Alias
UMLS CUI [1]
C4062077

Similar models

GSK study: Ropinirole in RLS patients 101468/243 - Enrolment, Previous study information and eligibility

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Previous study information
C2603343 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
C0205156 (UMLS CUI-3)
visit date
Item
Visite date
date
C1320303 (UMLS CUI [1])
Previous Protocol Number
Item
Previous SB Protocol Number
text
C2348563 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
previous centre number
Item
Previous Centre Number
text
C0019994 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
Previous Patient Number
Item
Previous Patient Number
text
C1830427 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Item Group
Please complete the following inclusion criteria
C1512693 (UMLS CUI-1)
Item
Subjects who have successfully completed Studies 101468/191,194 (US subjects only), or 207
integer
C2348577 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Code List
Subjects who have successfully completed Studies 101468/191,194 (US subjects only), or 207
CL Item
yes (1 )
CL Item
no (2 )
Item
The subject must have given written informed consent prior to any specific study procedures
integer
C0021430 (UMLS CUI [1])
Code List
The subject must have given written informed consent prior to any specific study procedures
CL Item
yes (1 )
CL Item
no (2 )
Item Group
Please complete the following exclusion criteria.
C0680251 (UMLS CUI-1)
Item
Women of childbearing potential who are not practicing a clinically accepted method of contraception such as oral contraception, surgical sterilization, I.U.D., diaphragm in conjunction with spermicidal foam and condom on the male partner, or systemic contraception (i.e., Norplant*).
integer
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Code List
Women of childbearing potential who are not practicing a clinically accepted method of contraception such as oral contraception, surgical sterilization, I.U.D., diaphragm in conjunction with spermicidal foam and condom on the male partner, or systemic contraception (i.e., Norplant*).
CL Item
yes (1 )
CL Item
no (2 )
Item
Women who have a positive pregnancy test.
integer
C0240802 (UMLS CUI [1])
Code List
Women who have a positive pregnancy test.
CL Item
yes (1 )
CL Item
no (2 )
Item
Subjects who have developed any medically unstable illnesses
integer
C4062077 (UMLS CUI [1])
Code List
Subjects who have developed any medically unstable illnesses
CL Item
yes (1 )
CL Item
no (2 )

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial